Results 171 to 180 of about 77,402 (300)

Moving beyond symptom management in long COVID guidelines: incorporating reinfection history, biological characterisation and health inequalities. [PDF]

Eur Respir J
Yang C, Espín E, Tebbutt SJ.
europepmc   +1 more source

Helen Salisbury: Prolonging omicron [PDF]

BMJ, 2022
openaire   +2 more sources

Extracellular ionic concentration modulates arrhythmias in a simulated population of human ventricular myocytes with long QT syndrome type 3

The Journal of Physiology, EarlyView.
Abstract figure legend Schematic illustrating the in silico study pipeline. A total of 50,000 virtual myocytes were generated, which were then filtered to 7093 myocytes that fit experimentally constrained biomarkers for physiological electrical and calcium behaviour under wild‐type conditions.
Katherine Flannery, Jacob A. Miller, Steven Poelzing, Seth H. Weinberg   +3 more
wiley   +1 more source

Omicron SARS-CoV-2 maternal infection is associated with favorable fetomaternal outcomes and fewer placental vascular malperfusion lesions compared with previous variants. [PDF]

AJOG Glob Rep
Remoué A, Suazo Y, de Moreuil C, Morcel K, Tremouilhac C, Sauvée C, Uguen A, Marcorelles P.   +7 more
europepmc   +1 more source

Metformin at the Time of COVID‐19 Infection and Risk of Long COVID: A Target Trial Emulation Study

Journal of Medical Virology, Volume 98, Issue 11, November 2026.
ABSTRACT Our objective was to evaluate metformin prescribed at the time of SARS‐CoV‐2 infection on the risk of developing Long COVID (LC) in electronic health record data. We conducted a new user analysis of metformin prescribed within 6 days of documented infection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) versus experimental ...
Carolyn T. Bramante, Til Stürmer, Jared D. Huling, John B. Buse, Christopher Lindsell, Thomas Stewart, Russell L. Rothman, David Sahner, Sarah E. Dunsmore, Eric Topol, Talia D. Wiggen, Steve Makkar, Andrew Toler, Taylor Estepp, Steven G. Johnson, N3C Consortium   +15 more
wiley   +1 more source

Genomic surveillance of SARS-CoV-2 in Tunisia during the omicron era: insights from the national influenza & other respiratory viruses laboratory. [PDF]

Virol J
Hamzaoui Z, Ferjani S, Bouchouicha T, Charaa L, Landolsi I, Medini I, Ben Ali R, Chammam S, Abid S, Kanzari L, Ben Sassi M, Trabelsi S, Boutiba Ben Boubaker I.   +12 more
europepmc   +1 more source

Omicron: The tsunami??

Indian Journal of Health Sciences and Biomedical Research (KLEU), 2022
openaire   +2 more sources

Does COVID‐19 Vaccination Protect Against Post‐COVID Cardiovascular Conditions?

Reviews in Medical Virology, Volume 36, Issue 6, November 2026.
ABSTRACT Cardiovascular diseases, such as acute myocardial infarction, heart failure, and arrhythmias, have been associated with SARS‐CoV‐2 infection, representing an important cause of long‐term morbidity and mortality. In addition to preventing primary infection, COVID‐19 vaccination has emerged as a protective factor against post‐COVID ...
Lidian Franci Batalha Santa Maria, Márcio Coutinho Xavier Naves, Elisabeth Carmen Duarte, Isis Polianna Silva Ferreira de Carvalho, Henry Maia Peixoto   +4 more
wiley   +1 more source

The emergence of new SARS-CoV-2 omicron subvariants introduces uncertainty about the end of the COVID-19 pandemic

Frontiers in Medicine, 2022
Severino Jefferson Ribeiro da Silva
doaj   +1 more source

Outcomes of immunocompromised and non-immunocompromised patients in the ICU diverge late in the pandemic. [PDF]

PLoS One
Battu S, Moore AR, Lebold K, Pacheco-Navarro A, Pienkos S, O'Donnell C, Sanchez P, Parmer-Chow C, Roque J, Ramaswamy T, Wilson JG, Levitt JE, Collins W, Rogers AJ.   +13 more
europepmc   +1 more source